Johnson & Johnson (JNJ) — closed signal from September 25, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on December 24, 2025.
Predicted vs. what happened
What happened
Reached its target in 49 days.
The thesis — published September 25, 2025
Short-term idea around the upcoming earnings update. A common short-term signal says the stock looks worn out after selling, while the recent average price is nudging higher. The Oct 14 report could move the stock, and JNJ's long record of paying and raising dividends adds stability. Results have been softer, so any reassuring outlook could lift shares over the next 0-3 months. Start small and use clear sell-stops.
Primary drivers
- Earnings on Oct 14 could spark a move if the message is confident
- Long history of rising dividends offers stability when markets get choppy
- Short-term reset hint; recent average price is edging up, aiding a rebound
- Business trends are slower, so careful sizing and protection are important
How it played out
JNJ: target reached in 49 days
Lyra published JNJ at $176.69 on 2025-09-25 as a short-term idea with 10% expected growth. The thesis pointed to the Oct 14 earnings update, a long dividend record, a short-term reset after selling, and a recent average price that was edging up. It also noted slower business trends and called for careful sizing.
Inside the window, JNJ reached the $193.13 target in 49 days. The stock peaked at $215.19 on 2025-12-15, with a 21.8% peak gain. It ended the window at $207.78. The thesis played out, and the move went beyond the published target.
What happened during the window
On Oct 14, 2025, Johnson & Johnson reported third-quarter sales of $23.99 billion and adjusted earnings of $2.80 per share. The same day, the company announced plans to separate its orthopedics business, DePuy Synthes.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.